I agree with your thoughts, @kervio. Great summary, thank you.
I am now treating aGVHD as a bonus.. Still hopeful, but not expecting the FDA to reverse their decision.
On another point, are we expecting data to be released for the first 30% of the ARDS trial at the 45% look in?
MSB to dispute FDA finding in Type A meeting, page-370
-
- There are more pages in this discussion • 648 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.023(1.89%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.383M | 3.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 50608 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 43900 | 9 |
View Market Depth
| Last trade - 14.12pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |